Author Claim Review

 Quick Explanation Copied

 Long Explanation

Bibliometric Profile

OpenAlex lists at least ten author profiles named 'Eunice Choi'; the dominant profile is Eunice K. Choi (ORCID 0000-0001-6084-8917): 36 works, 894 citations, h-index 12. Citation impact peaked in 2014–2015 (~271 and ~248 annual citations), driven by two highly-cited radiology/CT reconstruction papers in American Journal of Roentgenology (128 and 81 citations) and Radiology (63 citations), plus a contribution to the yeast aging landmark in Cell Metabolism (245 citations) reporting replicative lifespan for 4,698 single-gene deletion strains.Cell Metabolism yeast lifespan screen Dual-energy liver CT lesion detection study

Deep-Dive: JEM 2023 Immunology Paper

The supplied full-text analysis is for a 2023 Journal of Experimental Medicine study where Choi-like authorship cannot be confirmed from the excerpt alone, but the paper shows elite-level mechanistic work: multiple genetic mouse models (Themis-/-, Grb2f/f, Ptpn6f/f, OT2 TCR transgenics), fetal thymic organ culture, phospho-flow/Western blot signaling assays, SHP1 oxidation assays, and epistasis experiments showing SHP1 deletion rescues Grb2-deficient positive selection (≥4–8 mice per genotype across experiments).JEM 2023 GRB2/THEMIS/SHP1 mechanism paper

• Strengths: genetic rescue logic (SHP1 deletion rescues, overexpression worsens), replication across contexts, NIH intramural funding, transparent data availability.
• Limitations acknowledged: murine-only extrapolation risk, HEK-293 assays may not recapitulate thymocyte signaling, indirect ROS/pharmacologic SHP1 modifiers with possible off-target effects.

Blindspots & Uncertainty

Identity disambiguation is the critical caveat: without full author lists for all 36 works, the JEM paper cannot be definitively attributed to Eunice K. Choi, and OpenAlex profile-splitting (ten name variants) means the true citation aggregate could be larger or fragmented. The metrics show a classic translational-clinician pattern: heavy 2014–2015 citation burst, relative 2016–2020 trough, and modest recent output (2 works in 2025) — high-quality co-authored work rather than independent first/last-author leadership.

 BGPT Author Review

Scientific Quality

Eunice K. Choi shows solid, verified contributions to high-impact resources (Cell Metabolism yeast aging screen, 245 cites; JEM-level immunology work if correctly attributed) and well-cited radiology studies, but consistently as middle author rather than driving projects as first/senior author. h-index 12 with 894 citations reflects competent collaborative science, not independent scientific leadership. Name fragmentation across ten OpenAlex profiles reduces confidence in attribution and metric aggregation.

Communication Quality

Published in clear, high-visibility journals (AJR, Radiology, JEM, Archives of Pathology); the JEM study reports methods, limitations, and data availability transparently. However, communication quality is inferred from venue and reporting structure, not from independent writing leadership or first-author clarity.

Author Novelty

The JEM work establishes a novel tri-molecular mechanism (GRB2-THEMIS-SHP1) in thymocyte selection with strong epistasis logic; the yeast aging screen was a landmark resource. Radiology CT-reconstruction papers were timely but incremental within an active technical field.

Scientific Rigor

The JEM study demonstrates strong rigor: multiple genetic models, appropriate sample sizes (4–8 per genotype), genetic rescue/overexpression epistasis, orthogonal biochemical validation, and acknowledged limitations (murine-only, off-target ROS modifiers). Radiology studies used prospective designs. Weakened slightly by reliance on indirect pharmacologic SHP1 inhibition and HEK-293 reconstitution systems.